We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Philips to Acquire MRI Components Manufacturer

By MedImaging staff writers
Posted on 12 Jul 2006
A strategic acquisition has been devised to build magnetic resonance imaging (MRI) systems with extended product range, accelerated time-to-market, and increased efficiency. More...


Philips Medical Systems (Best, The Netherlands) has signed a definitive agreement with Intermagnetics General Corp. (Latham, NY, USA), under which Philips will acquire Intermagnetics for US$27.50 per share or a total equity value of approximately $1.3 billion (EUR 1 billion) to be paid in cash upon completion. Completion of the transaction is subject to regulatory approval, to the terms and conditions of the merger agreement and to the approval of Intermagnetics' shareholders.

Intermagnetics develops, manufactures, and markets high-field superconducting magnets used in MRI systems and is viewed as the technologic innovator in this market. Intermagnetics also provides specialized MRI-compatible patient monitoring devices and radiofrequency (RF) coils that are mostly supplied to hospitals.

The acquisition of Intermagnetics will strengthen Philips' position in the key market of MRI. It will allow Philips to considerably rationalize its supply chain, to enhance its competitive position, and to participate in the fast growing market for RF coils. Philips anticipates the transaction to be accretive to its operating margin towards the end of 2007. There will be a one-time charge of approximately EUR 85 million related to in-process R&D expenses, integration of supply chain, and various purchase accounting items, taken in the latter half of 2006.

Philips also recognizes the benefits provided by the cutting-edge technology of SuperPower, Intermagnetics' energy technology subsidiary, and will actively consider the most efficient way to achieve its potential.

In 2005, total MRI market was approximately EUR 5 billion, and consisted of MRI systems, services, and accessories (such as RF coils). Over the past 10 years, the number of MRI procedures grew on average by 10% per year. This has been driven by an increasing number of diagnostic applications. MRI is radiation-free, and is the preferred technique for high-resolution imaging of the brain, spine, abdomen, breast, prostate, blood vessels, and of all joints in the body.

Intermagnetics' headquarters in Latham, NY, USA, will become the global headquarters of Philips' enlarged magnetic resonance business.



Related Links:
Philips Medical Systems
Intermagnetics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
X-Ray Meter
Cobia SENSE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.